Vector Psychometric Group (VPG)

VPG is a psychometric consulting and software company dedicated to providing clear direction to people trying to answer important and difficult questions.

[Vector Psychometric Group (VPG) @VPGCentral]

MiCOAS is an FDA-funded project that is part of a broader effort to incorporate the patient voice into migraine clinical trials.

Click the video to learn more.

#migraine #headache #patients #trials

[Vector Psychometric Group (VPG) @VPGCentral]

Thanks @HeadacheJournal and major thanks to our participants in the FDA-sponsored #MiCOAS qualitative interview studies who taught us about the ways #migraine can impact people's lives. We are using these insights to develop improved measurement strategies for clinical trials!

[Headache Journal @HeadacheJournal]

Open Access:
Recent data from the #MiCOAS project demonstrates #migraine impacts individual functioning in multiple ways & the nature of these impacts can be dependent on social-contextual factors
Rikki Mangrum MLS, @DawnBuse et al
https://t.co/LhUUJoMCtg

[Vector Psychometric Group (VPG) @VPGCentral]

Talking to individuals with migraine courtesy of @CoalitionCHAMP confirmed that #migraine is more than head pain and symptoms differ across all phases of the migraine cycle.

Work presented at the 2022 @ahsheadache scientific meeting.

#MiCOAS

[Vector Psychometric Group (VPG) @VPGCentral]

Did you know that the COVID‐19 pandemic has resulted in both negative and positive impacts for people living with migraine?

@DawnBuse has a paper (free access) in @HeadacheJournal based on our #MiCOAS qualitative study.

https://t.co/4I2WiuOAn2

[Vector Psychometric Group (VPG) @VPGCentral]

Dr. Carrie Houts (Director, Psychometrics @VPGcentral) just published a paper in @ISOQOL QOLR discussing how measurement science can help fill evidence gaps when re-purposing scales for new use cases.

#psychometrics #PROMs #COAs

https://t.co/aMOZYWB6kJ

[Vector Psychometric Group (VPG) @VPGCentral]

Dr. RJ Wirth will be presenting today at #DIA2022 as part of Session 366: Development of Standard Core Sets of Clinical Outcome Assessments and Related Endpoints.

Hope to see you there!

#PROMs #Migraine #headache @druginfoassn

[Vector Psychometric Group (VPG) @VPGCentral]

New @HeadacheJournal manuscript focused on the clinical utility of the patient‐identified most bothersome symptom measure from PROMISE‐2 for research in #migraine prevention.

Authors include Dr. Lipton and members of VPG.

https://t.co/PrI2u83o1b

[Vector Psychometric Group (VPG) @VPGCentral]

Dr. Wirth will be discussing #MiCOAS @ 4:15pm tomorrow at #DIA2022 in Chicago!

Drop by and ask some questions!

#PROMs #Migraine @druginfoassn

[Vector Psychometric Group (VPG) @VPGCentral]

Congrats to Dr. Cai, CSO @ VPG, on the well-deserved award!

#psychometrics #education #learning

[UCLA CRESST @UCLA_CRESST]

Please join us in congratulating @UCLA_CRESST Dir., Professor Li Cai — this year's winner of The Bobbie & Mark Greenfield Faculty Award for Applied Research in Learning & Achievement.
Thank you, Li, for your contributions to the Center, School, University, & research community!

[Vector Psychometric Group (VPG) @VPGCentral]

Attending the DIA 2022 meeting next week?

Mark your calendar. Dr. Wirth will be discussing #MiCOAS @ 4:15pm on 6/22 (Wed).

#DIA2022 #PROMs #Migraine @druginfoassn

Development of Standard Core Sets of Clinical Outcome Assessments and Related Endpoints https://t.co/O1Qwd9p1QZ

[International Headache Society @ihs_official]

Each year in June, headache communities worldwide raise awareness of Migraine. Migraine is most common in those aged 30 to 39, an age span in which prevalence in males and females reaches 7 and 24 percent. Lipton et al., Neurology. 2007

#migraineawareness2022 #mham2022

[Vector Psychometric Group (VPG) @VPGCentral]

@beth_morton Correct! The MiCOAS project. We actually worked with CHAMP during the first phase of the project. Lots of work with patients - several pubs focused on patient input on the way.

https://t.co/T3A9TeJt7I

[Vector Psychometric Group (VPG) @VPGCentral]

@beth_morton Individual differences within and across individuals with regards to headache day severity...

https://t.co/zfaaRADK74

[Vector Psychometric Group (VPG) @VPGCentral]

@beth_morton We've done some research that tries to capture the importance of individual differences in migraine (this is understudied IMO)...

https://t.co/Qolqd12Nf5

[Vector Psychometric Group (VPG) @VPGCentral]

VPG is lucky to have Dr. Goadsby as an ETAC member on the MiCOAS project... Congrats Dr. Goadsby! @petergoadsby

[Headache Journal @HeadacheJournal]

On behalf of the @HeadacheJournal Editorial Board, congratulations to @ahsheadache immediate past President @petergoadsby on the Graham Award at #AHSAM22! 🎉 Thank you for your contributions to #headache medicine science & mentorship of so many of us!

[Olivia Begasse de Dhaem, MD, FAAN, FAHS (she/her) @obegassededhaem]

Great talk by Dr Rikki Mangrum. Need to involve the people you intend to benefit when developing patient-reported outcome measures. Function & emotion are integral parts of pain experience #AHSAM22 @VPGCentral

[Vector Psychometric Group (VPG) @VPGCentral]

@ahsheadache @Robert_Gibler @SengElizabeth @AmynahPradhan At yesterday's #AHSAM22 plenary, RJ got a question about MIDs. Below is a recent pub from @HeadacheJournal on HIT-6 by Dr. Houts that gives more details on methods.

https://t.co/nrbLKefakS

[Vector Psychometric Group (VPG) @VPGCentral]

Dr. RJ Wirth will be presenting on “What Should be the Primary Outcome?” for the #AHSAM22
plenary on “Design and Interpretation of Headache Research and Clinical Trials” (Adams A)

#MiCOAS #PROMs

@ahsheadache @Robert_Gibler @SengElizabeth @AmynahPradhan

[Vector Psychometric Group (VPG) @VPGCentral]

MiCOAS - Integrating the patient voice into migraine endpoints/outcomes. Our team has #AHSAM22 talks & posters!

Today (6/10)
Dr. Houts (1:50pm, Theater 3)
Dr. Wirth (4:10pm, Adams A)

@ahsheadache @CoalitionCHAMP @DawnBuse @petergoadsby @daviddodick @JSico_MD @GoldenGraine

[Matt Hoffman @byMattHoffman]

#AHSAM22: The director of the @MontefioreNYC Headache Center spoke about the Migraine Clinical Outcome Assessment System (or MiCOAS) project and the need for better patient-reported outcome measures in #migraine clinical care.
https://t.co/l0damOgLcX

[Vector Psychometric Group (VPG) @VPGCentral]

@ahsheadache @HeadacheJournal Dr. Ailani's Required Reading 2 #AHSAM22

@ahsheadache @HeadacheJournal

Systematic review of outcomes and endpoints in acute migraine clinical trials https://t.co/NVdRybzAtT

[Vector Psychometric Group (VPG) @VPGCentral]

Dr. Ailani's Required Reading 1 #AHSAM22

@ahsheadache @HeadacheJournal

Systematic review of outcomes and endpoints in preventive migraine clinical trials https://t.co/ReJvOrHa3Q